Rectal methohexital has been used for nearly 30 yr in pediatric anesthesia. Despite this long and increasingly varied use, no large prospective series has been published detailing safety and efficacy. This study prospectively evaluated the efficacy, safety, and side effects of this medication in a series of 648 cases. On 553 of 648 occasions (85%), the child fell asleep after a single 30-mg/kg dose of 10% methohexital.
Sleep was less likely in patients with myelomeningocele or who were receiving oral phenobarbital or phenytoin. When sleep occurred, the average time to onset of sleep was 6 min. Most patients who remained awake 15 min after drug were sedated. Defecation (10%) and hiccups (13%) were common but benign side effects. Partial airway obstruction and/or desaturation to Spo, 5 93% occurred in 26 patients (4%), but was resolved with blow-by oxygen and/or jaw-thrust in all but two cases. These two patients (0.3% of total) required aggressive airway intervention by the supervising anesthesiologist.
Apnea did not occur in any patient. Methohexital has a high efficacy rate for sleep (85%) or sedation (96%/o), and has a relatively rapid onset. Significant respiratory side effects occur infrequently, but can be life threatening if not properly managed. (Anesth Analg 1995; 81:957-61) R ectal methohexital has been used for the anesthetic induction of young children for nearly 30 yr (1). Efficacy rates for the induction of sleep are reported in the 85%-100% range* (2-5). Side effects have typically been minor and include defecation and hiccups, but oxygen desaturation" (2) and varying degrees of airway obstruction (1, 5, 6) complications of rectal methohexital. We report a prospective series of more than 600 patient experiences with rectal methohexital.
Methods
This prospective study was reviewed and approved by the University of Kentucky Human Subjects Committee and by the patient research committee of the Shriners' Hospital for Crippled Children. Study cases consisted of all electively scheduled patients who were to receive rectal methohexital for induction of anesthesia. The choice of rectal methohexital as the induction drug was made by the attending anesthesiologist independent of study considerations, and no prior premeditations were used.
Upon arrival in the preoperative holding area, baseline measurements of oxygen saturation (Spoz) and heart rate were obtained using a Nellcor N-200@ (Nellcor Inc., Hayward, CA) pulse oximeter. This monitor was left in place except in patients who would not tolerate the continued presence of the probe. In those cases the probe was removed and then replaced after the onset of sufficient sedation or sleep. Oxygen desaturation was defined as Spoz 5 93%, and desaturation episodes were treated with blow-by oxygen followed by jaw thrust and All data are given as mean t SD. a "Other" refers to all uatients not on anticonvulsants or bearing the diagnosis of cerebral palsy or myelomeningocele * P < 0.05 vs values fdr Other group.
" " other supportive measures as necessary. Partial or complete airway obstruction, apnea and/or seizure activity were specifically included in our prospective observation. Other side effects or complications were also part of our prospective evaluation and were recorded until other anesthetics were given. Side effects which occurred after the use of other anesthetics were not considered responses to methohexital. The single exception to this rule was defecation, which was tracked and recorded through admission to the postanesthesia care unit. Each patient received a single dose of 30 mg/kg of a 10% solution of rectal methohexital. The methohexital was reconstituted in sterile water and a syringe containing the solution and 2-3 mL of air (to ensure complete drug delivery) was used to inject the solution via a short piece of lubricated 14-gauge suction catheter. Onset of sleep was defined as loss of consciousness and lack of spontaneous movement coupled with no response to verbal stimulation; the time of sleep was recorded. All children who fell asleep were placed on a stretcher in the supine or lateral position, with care taken to avoid neck flexion and thus help maintain airway patency. Each patient was observed for a minimum of 15 min after drug administration, in order to allow serum methohexital levels to peak (3,9). All patients were assessed 15 min after drug administration and were classified as asleep, heavily sedated (minimal or no response to verbal stimulation), moderately sedated (some response to verbal stimulation but no signs of anxiety), or as having had no apparent response to methohexital. All medication administration, monitoring, and patient observations in this study were completed by the nursing staff in constant attendance in the preoperative holding area, with an attending anesthesiologist immediately available for assistance and/or consultation. Means to maintain the airway, to ensure ventilation, and suction equipment were at the bedside as a matter of routine.
We also performed separate analysis of results in patients with myelomeningocele (MM0 or cerebral palsy (Cl'), or who were taking phenobarbital or phenytoin for seizure disorders. These groups were then compared to a control group comprised of all other patients.
Statistical analysis was performed using t-tests and Mann-Whitney U-tests for demographic information and time to onset of sleep. Fisher's exact test was used to compare success rates as well as the incidences of side effects between groups. Statistical significance was defined as P < 0.05.
Results
There were 664 consecutive administrations of rectal methohexital recorded in the study. Twenty-six were excluded because of incomplete data recordings or departures from study protocol. There were no significant complications in this group of 26 patients. The remaining 434 patients received rectal methohexital on 648 occasions (Table 1) . No patient was in the study more than three times, and no patient return was at less than a 3-wk interval. Children with Cl? accounted for 63 cases (Cl' group), 54 were patients with MMC (MMC group), and 19 children were receiving phenobarbital or phenytoin for seizure disorders (Anticonvulsant group). Five hundred twelve cases occurred in patients bearing a variety of other diagnoses (Other group).
Of the total 648 cases, 553 (85%) fell asleep after rectal methohexital. The average time to onset of sleep was 6 + 2 min, with a range of 2-12 min. In the 95 cases where sleep did not occur, 24 were heavily sedated, 42 were moderately sedated, and in 29 cases (4%) no observable sedation occurred (Figure 1) .
Defecation (67 cases, 10%) and hiccups (85 cases, 13%) were relatively common, but were associated with no patient morbidity. Specifically, the occurrence of hiccups did not predict or correlate with oxygen desaturation. Desaturation to Spo, 5 93% occurred in 26 of 648 cases (4%). In 24 of these 26 episodes, blow-by oxygen alone (n = 19) or in combination with a jaw-thrust maneuver (n = 5) was adequate to maintain airway patency and to restore Spo, to acceptable levels. In two cases (0.3% of the total) laryngospasm or Heav Sedate = those who were heavily sedated. n, More patients in the Anticonvulsant and myelomeningocele (MMC) groups showed no effect than in either the cerebral palsy (Cl') group (P < 0.05) or Other group (P < 0.001). b, The sleep rates in the Anticonvulsant and MMC groups were lower than in the b&r group (P -< 0 001 and 0.05, respecti<ely).
total obstruction occurred and aggressive airway management with positive pressure ventilation was necessary. Complete apnea with absence of respiratory effort was not seen in any patient, nor did seizures occur.
The group of patients with Cl' was older and heavier than the control (Other) group. The children on anticonvulsants and those with MMC were also older than those in the Other group, but there were no weight differences. In patients who fell asleep, there were no intergroup differences for time to onset of sleep (Table 1 ). There were no differences between groups in the incidence of hiccups or of oxygen desaturation and/or airway obstruction.
The overall incidence of defecation was higher in the MMC group than in any of the other groups (Table 2) , and there was also an increased incidence of immediate defecation in the MMC patients.
The success rate for sleep and the levels of sedation in wakeful patients ( Figure 1) were nearly identical in the Cl' and Other groups, and were comparable to the values for all patients. The MMC and Anticonvulsant groups were markedly different in their responses (Figure 1) . Sleep rates were lower in both groups (78% and 32%, respectively) than in the Other group (88%). Also, a significant percentage of the MMC and Anticonvulsant groups were unaffected by methohexital (17% and 47%, respectively), as opposed to only a 2% incidence of complete failure to sedate in the Cl' or Other groups.
Discussion Airway Compromise
Rectal methohexital is a potent sedative medication, and has been described and treated as a drug for induction of general anesthesia (lo), to be given by the anesthesiologist only when he or she can remain in attendance. Furthermore, although methohexital has a benign hemodynamic profile (11,121, it has been indicted as causing oxygen desaturation (21, seizures (71, and apnea (8). The incidence of such serious reactions is unknown.
In 648 cases we observed 26 episodes (4%) of partial airway obstruction or of Spo, decreasing to 593%. Nineteen of these cases responded to blow-by oxygen, and five children required a jaw-thrust in addition. On two occasions, however, there were serious airway problems requiring aggressive intervention. There was one episode of moderately severe laryngospasm and one of essentially complete oropharyngeal airway obstruction.
Both episodes required positive pressure ventilation, with urgent intubation in the first case and placement of an oropharyngeal airway in the latter. Thus, although this medication was given by nursing staff, such personnel must be properly trained and must have at hand means to deliver supplemental oxygen, positive pressure ventilation, suction, and appropriate monitoring. Standards for deep sedation (131, if not standards for general anesthesia, should be met. Most importantly, a supervising anesthesiologist must be immediately available to respond to the rare episodes of airway compromise or other complications which might require aggressive intervention. One recent retrospective study-of 190 uses of rectal methohexital to facilitate diagnostic imaging has found the drug to be "safe, efficient and effective sedation for most children" (14). We agree, but would caution that, as with all sedative drugs, real danger exists. A series of 190 cases is significant, but we had completed more than 300 cases in our study before we saw our first patient with serious airway compromise. Rectal methohexital must not be used in a busy imaging department where the radiologist is in another There were no significant between-group differences for the incidence of hiccups or desaturation 2 obstruction. ' Denotes a higher incidence of defecation in the rnyelomeningocele cases; P < 0.01 vs cerebral palsy group and P < 0.001 vs Other. b Denotes two patients who developed desaturation with obstruction and who required aggressive airway intervention.
room performing other tasks, or under the supervision of anyone not prepared to handle an airway crisis.
Efficacy
The efficacy of rectal methohexital is often measured as its ability to cause sleep, and the sleep rate in our patients was 85%, with an average onset of sleep in 6 min. The extremes of time to sleep were 2 and 12 min. This window for sleep onset reflects the variability of rectal absorption (151, but also documents the rapid onset of methohexital. Most patients who did not sleep were measurably sedated at 15 min after drug administration, with only 4% of patients remaining alert. Efficacy was less in patients with MMC and in patients receiving phenobarbital or phenytoin (Figure 1 ). Decreased success with methohexital in patients on anticonvulsant therapy has been reported previously (16). Despite a protocol to repeat the entire 30-mg/kg dose of methohexital should sleep not occur, only two of Griswold and Liu'st eight patients on anticonvulsants fell asleep, as opposed to 31 of 32 patients on other or no medications. Our results agree: patients on phenobarbital or phenytoin are unlikely to be sedated by rectal methohexital. Almost half of the patients in the Anticonvulsant group showed no sedative effect, as opposed to only 2% of the patients in the Other group. Enzyme induction and neuronal tolerance probably account for this finding.
Phenobarbital and phenytoin are enzyme-inducing drugs (17,18), with well-known effects on hepatic microsomal enzyme function. These drugs may also have the effect of increasing hepatic blood flow (19). Chronic barbiturate use may double the metabolism of many drugs, including that of shorter-acting barbiturates (20) . In addition to these effects, neuronal tolerance to the sedative effects of the barbiturates also develops with acute and/or chronic use. Maximum tolerance may increase the required effective barbiturate dose sixfold (21). Patients with MMC also had a decreased incidence of sleep, but for a different reason. Although defecation occurred in all patient groups, immediate defecation, i.e., loss of liquid medicine and/or stool coincident with removal of the administration catheter, occurred in only six patients, five of whom were in the MMC group. None of the patients in whom immediate defecation occurred were sedated. (Later defecation did not correlate with success or failure.) If one excludes those patients with immediate defecation, results in the MMC group would be comparable to those in the CP and Other groups. In the presence of a patulous anal sphincter, then, higher administration of the drug, as described by Khalil et al. (22) , might be particularly advantageous.
Other Side Effects
Previously reported side effects, such as defecation and hiccups, were noted in this study as well, and with generally comparable incidences (1,3-5). Hiccups were relatively frequent (Table 2) , occurring in 13% of cases, and occurred either before or after onset of sleep. They were not associated with airway compromise or oxygen desaturation, and no specific treatment was given or needed.
Seizures did not occur in any patient in this report, nor in any of the excluded patients. However, exacerbation of seizures by rectal methohexital has been reported only in children with temporal lobe epilepsy (7), and there were no such patients in our series.
Apnea has been reported with use of rectal methohexital in two children with MMC (8). This may have been related to barbiturate effects on a brainstem already affected by the Arnold-Chiari malformation. Complete apnea with absence of respiratory effort did not occur in any patient in our study, including the 54 cases with MMC. This number is too small to say that these children are not at special risk (23), but apnea from rectal methohexital must be a relatively uncommon occurrence.
